Dr. Cameron graduated from East Anglia University (Norwich, UK) and obtained a doctorate (D.Phil.) from Sussex University (Brighton, UK). After completing postdoctoral positions in the UK and internationally, Dr. Cameron was awarded a Personal Chair in Vascular Neurobiology at the University of Aberdeen (Aberdeen, Scotland, UK). Currently he is Emeritus Professor of Physiology at Aberdeen. Dr. Cameron has published more than 150 original papers, reviews and book chapters. He is currently the Editor-in-Chief of this journal (Current Diabetes Reviews), published by Bentham Science Publishers.
Joseph L. Evans, Ph.D., is Executive Manager, Research and Development, Stratum Nutrition (Saint Charles, MO, USA), and a Novus International Science Fellow. Dr. Evans holds a Ph.D. in Biochemistry from Drexel University, and received post-doctoral training in physiology and pharmacology at Dartmouth Medical School and the Panum Institute. Dr. Evans’ translational research experience extends from mechanistic research through randomized, controlled, clinical trials, and has successfully focused on the discovery and commercialization of pharmacological and nutritional interventions for the metabolic and cardiovascular diseases. Dr. Evans has published approximately 80 peer-reviewed scientific papers, review articles, book chapters, abstracts, and US patents.
Dr. Hoffman obtained his medical degree (M.D.) from The Ohio State University College of Medicine. He did his pediatric residency at the Akron Children’s Hospital and his pediatric endocrinology fellowship at Children’s Hospital of Pittsburgh. He is currently a Professor of Pediatrics and Program Director for the Pediatric Endocrinology Fellowship at Nationwide Children’s Hospital and The Ohio State University. His research interests are type 1 diabetes, hypoglycemia and the cardiovascular endocrinology.
Dr. Sil is currently a senior professor and research coordinator of the “Molecular Medicine” program of Bose Institute, Calcutta, India. He has more than 25 years of research experience in several major areas of chemicals, drugs as well as environmentally exposed nanostructure-induced and oxidative stress mediated organ pathophysiology. Previously, Dr. Sil served as the “Head” of the Division of Molecular Medicine at Bose Institute. Dr. Sil holds a Ph.D. degree in Chemistry from the University of Calcutta and conducted Postdoctoral research at the Cleveland Clinic Foundation, Cleveland, Ohio, USA. Dr. Sil authored more than 130 manuscripts and 8 book chapters; serving as reviewers of more than 170 journals, an Associate Editor of “Toxicology Reports” and an Editorial Board Member of “Heliyon”.
Dr. Hernaez-Ortega obtained a doctorate (Ph.D.) in Ophthalmology from the University of Valladolid (Spain), and completed her training in vitreoretinal surgery at the Bascom Palmer Eye Institute (Miami, USA) and the Jules Stein Eye Institute (Los Angeles, USA). Dr. Hernaez-Ortega is a member of the Spanish Retina and Vitreous Society (SERV) and the European Society of Retina Specialists (EURETINA). She has nearly 20 years of experience in the research and medical-surgical treatment of diabetic eye complications. Dr. Hernaez-Ortega has authored and co-authored more than 30 scientific manuscripts and book chapters.
Dr. Qi obtained a medical degree in China and PhD at Tufts University in the United States. He is now HCA Regents Distinguished Chair and Professor in Tulane University and Adjunct Professor at Harvard T.H Chan School of Public Health. He has published more than 210 scientific publications and edited a textbook.
Prof. Anoop Misra is the Chairman, Fortis-CDOC Center of Excellence for Diabetes, Metabolic Diseases, and Endocrinology, New Delhi, India and has been a faculty at the Department of Endocrinology at the Southwestern Medical Center in Dallas, Texas, USA, and All India Institute of Medical Sciences, New Delhi. He has lead consensus guidelines for obesity, the metabolic syndrome, physical activity, and diets for Asian Indians. His current research includes fatty liver and fatty pancreas in relation to insulin resistance and diabetes. He has been awarded highest award for medicine in India Dr BC Roy award (2006) and prestigious Indian National Honor, Padma Shree (2007).
Dr. Nikolaos Papanas is Associate Professor in Internal Medicine at Democritus University of Thrace, Greece. He has been specialized in diabetes and its complications in the Diabetes Center and the Diabetic Foot Clinic at King’s College Hospital, London, UK, as well as in the German Diabetes Center at the Heinrich Heine University, Düsseldorf, Germany. He has established an ongoing collaboration with the neuropathy study group of the German Diabetes Center in Düsseldorf. He has published more than 220 papers in peer-reviewed journals and serves in the editorial board of 25 international journals. He has also participated with numerous presentations in Greek and European medical congresses and repeatedly served as invited reviewer in medical journals. He has served in the Executive Committee of the Hellenic Society for Angiology. He is currently a member in the Executive Committees of the Diabetic Foot Study Group (DFSG) of the European Association for the Study of Diabetes (EASD), and of the Study Group on Diabetes and Nervous System of the German Diabetes Association (DDG). He is also a member of the Executive Committee of the Greek Society for the Study of the Diabetic Foot. He has served as Secretary General and is currently the President of the Hellenic Diabetes Association.
Dr. Shanhu Qiu received his M.D. training in Ulm University, Ulm, Germany. He is currently an Associate Professor (Associate Research Fellow) in the Department of Endocrinology in Zhongda Hospital, Southeast University, Nanjing, China. Dr. Shanhu Qiu has published more than 30 scientific peer reviewed articles, and his research interest includes exercise and physical activity in type 2 diabetes, the epidemiology of type 2 diabetes, as well as the weight management for type 2 diabetes.
Dr. Kota Ramana is a Professor at Department of Biomedical Sciences, Noorda College of Osteopathic Medicine, Provo, UT-USA. The chief objectives of his lab investigations are to examine the involvement of cellular metabolism and oxidative stress signals in inflammation and to delineate the role of aldo-keto reductases in mediating the inflammatory pathways. He uses various genetic, biochemical and cell biological approaches to analyze oxidative and inflammatory responses in the mediation of various secondary diabetes complications and cancer.
Dr. David Wagner did B.S. (Magna cum Laude) in Chemistry and Biology from King College, Bristol, TN/VA in 1984. He did his M.S. in Biochemistry from East Tennessee State University, Johnson City, TN in 1987. Lastly Ph.D. in Biomedical Sciences from East Tennessee State University, Quillen College of Medicine Johnson City, TN in 1994. Since 2010, Dr. Wagner is an Associate Professor in the Dept. of Medicine and Head of Section of Immunology Webb-Waring Center at University of Colorado Denver. He has numerous contributions, honors, awards and publications to his credit.
Professor Ernest Adeghate obtained his medical degree from Semmelweis University Medical School, Budapest, Hungary and his PhD and DSc from the Hungarian Academy of Sciences. He also has a Master degree in Family Medicine from Monash University, Australia. He is interested in the morphology of pancreatic grafts and the effect of neurotransmitters, neuropeptides and cytokines on parameters of metabolic disease, insulin release and on complications of diabetes mellitus. Prof. Adeghate has published more than 200 peer-reviewed articles. He is currently, the Editor-in Chief of The Open Medicinal Chemistry Journal published by Bentham Science Publishers.
Dr. Aguilar-Salinas is a specialist in Internal Medicine and Endocrinology. He graduated from the Instituto Nacional de Ciencias Medicas y Nutricion. He is a doctor of Clinical Investigation and a research follow at the Washington University, School of Medicine. He has published 275 articles in indexed journals. He is a member of the Mexican National Academy of Medicine and aformer president of the Mexican Society of Nutrition and Endocrinology (2009). His work has contributed to describe the epidemiology and genetics of type 2 diabetes and dyslipidemias in Mexicans.
Fabio Angeli is a Cardiologist and Biomedical researcher trained in cardiovascular medicine, particularly in the context of cardiovascular risk assessment, diabetes, kidney diseases, heart failure, acute coronary syndromes and maternal and neonatal healthcare. He has published more than 160 papers in reputed journals indexed by PubMed and has been serving as an editorial board member of several international leading Journals.
Prof Suleyman Aydin has received his PhD in Illinois Institute of Technology during the period of 1999. Currently, he is working at Medical School as Professor of Medical Biohemistry in Firat University. He has authored more than 175 research articles/books. He is currently also serving as scientific Reviewer for various academic journals He is a member of Organization Committee Members, Council Members,, The American Turkish Society, Turkish Biochemical Society and The Endocrine Society). He has honoured as Certificate in Laboratory Animal Science, Good Clinical Practice (GCP) and statistics, Certificate in Clinical Trial, Trainer’s Training Certificate and Pedagogical Formation Training Certificate.
Dr. Bakhtiyari received his Ph.D. in Clinical Biochemistry from Tarbiat Modares University School of Medicine in Iran. He is currently an Associate Professor and Principal Investigator in Molecular Diabetology and Molecular sciences in the Department of Clinical Biochemistry and the Biotechnology and Medicinal Plants Research Center at Ilam University of Medical Sciences in Iran. His research focuses on Insulin signaling pathway in type 2 diabetes, Molecular mechanism of insulin resistance and type 2 diabetes, Gene expression analysis in Insulin resistance and type 2 diabetes, and Molecular mechanism of lipid-induced insulin resistance. He has published nearly 60 peer-reviewed papers in journals.
Dr. Dandona is a Distinguished Professor of Medicine and chief of the Division of Endocrinology, Diabetes and Metabolism, at the University at Buffalo, The State University of New York, and the founder of the Diabetes–Endocrinology Center of Western New York in Buffalo. Dr. Dandona is a Rhodes Scholar from India, trained at the University of Oxford and the University of London. Dr. Dandona has published more than 540 papers in peer-reviewed medical journals, and has presented keynote lectures on diabetes and insulin resistance at many national and international conferences
Dr. Gu’s education background includes BSc in Animal Medicine (Nanjing, China 1982), MSc in Pathology (Nanjing, China 1988) and Ph.D. in Genetics (Uppsala, Sweden 1994). Currently, he is a Professor in Molecular Medicine and Director for Center of Pathophysiology, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China. Before then, he was an Associate Professor and Senior Researcher in Molecular Genetics and Epigenetics, Karolinska Institutet, Stockholm, Sweden. His research interests are mainly focused on molecular medicine and translation medicine in diabetes, obesity and diabetic nephropathy. He has published over 150 peer-reviewed articles in the international journals and chapters in five books related to diabetes and diabetic nephropathy. firstname.lastname@example.org
Dr. Hampe received her PhD at the Weizmann Institute of Science in Israel in 1997. She did her post-doctoral training in Dr. Åke Lernmark’s laboratory at the University of Washington, Seattle and is currently an Associate Professor at the Diabetes Research Institute at the University of Washington. She has 20 years of research experience focusing on autoimmune diseases including Type 1 diabetes and autoimmune neurological disorders. Dr. Hampe has authored over 100 manuscripts. She serves on study sections at the Juvenile Diabetes Research Foundation, the American Diabetes Association and NIH.
Dr. Kamoi obtained a doctorate (M.D.) in in Medicine from the University of Niigata, Japan. Dr. Kamoi also obtained a research fellow from the University of Indiana and Professor of Niigata University in April 2010 to March 2014. Currently, Dr. Kamoi is also a Director of Diabetes Mellitus & Disorders of hyothamic pituitary glands in Joetsu General Hospital, Japan. He has published more than 200 scientific publications. Dr. Kamoi is in the editorial board of Current Diabetes Review published by Bentham Science Publishers.
Dr. Ismail Laher is a Professor of Pharmacology and Therapeutics at the University of Pharmacology. He holds a degree in pharmacology from the University of London and graduate training in Canada and post-graduate training at the University of Vermont. Dr. Laher’s research interests are in vascular regulation (particularly of small arteries) in health and disease and the effects of exercise in improving endothelial function (e.g. in diabetes). More recent work focusses on the vascular function in rodent models of obstructive sleep apnea (especially in conjunction with underlying complications of diabetes / obesity).
Dr. Melpomeni Peppa is an Associate Professor of Endocrinology and Director of Endocrine and Bone Metabolic Disorders Unit of 2nd Propaedeutic Department of Internal Medicine & Research Institute, Attikon University Hospital in Athens, Greece. She is a member of the ERASMUS/CIVIS Committee for Medicine and Faculty Staff for the training of medical students in Internal Medicine. She had a postdoctoral Research fellowship (2000-2003) in Division of Experimental Diabetes and Aging, Department of Geriatrics, Mount Sinai School of Medicine, NY, USA, studying the role of advanced glycation end products and oxidative stress in diabetes, renal disease, aging, and their complications through in vitro, in vivo and clinical studies. Her research interests have focused on clinical, molecular and environmental aspects of metabolic and hormonal abnormalities in diabetes, obesity, metabolism, endocrine cancer and their complications. Her work has generated 75 publications in peer-reviewed journals. Also, Dr. Peppa has participated in many national and international conferences.
Demosthenes Panagiotakos is Professor of Biostatistics, Research Methods and Epidemiology. he is the vice Rector of Financial Affairs, Research and Development of the Harokopio University and Dean of the School of Health Science & Education at Harokopio University (2013-2016). Dr Panagiotakos is also visiting Professor at School of Arts and Sciences, Rutgers, the State University of New Jersey, visiting Professor of Medicine, at the Agricultural University of Athens. He is the Principal Investigator of 7 large–scale epidemiological studies. He has published 3 books, over 600 scientific papers in peer-reviewed international journals, as well as 50 papers in national journals and Conference proceedings and has more than 13.500 citations of his work (h-index of 55). He has received National and International Awards, Scholarships and many Awards from various Scientific Societies.
Dr. Alisa Phulukdaree is presently serving as an Associate Professor at the University of Pretoria. She completed her B. Sc and M. Sc in Medical Biochemistry from the University KwaZulu-Natal. She further obtained PhD in the same field from the same institution in 2013. She is serving as an editor/reviewer in different scientific journals. She has also been recognized with awards and prizes such as Exceptional Young Researcher Award from University of Pretoria, Professional Providence Society Scholarship and National Research Foundation Doctoral Scholarship. She has also contributed her valuable publications in different scientific journals.
Dr. Pitocco obtained degree with top marks in medicine and surgery in 1995 from Catholic University of Rome and Specialized in Endocrinology and metabolism in 2000. Currently, he is Chief Director of Diabetes care Unit of Foundation Agostino Gemelli Hospital and Associate Professor of Endocrinology in the Catholic University of Rome. He is the author of 146 papers with H-index=33 (Scopus). His main field of interest is the treatment of type 1 and type 2 diabetes and its complications (in particular diabetic foot) and diabetes in pregnancy. He was one of the authors of Italian Recommendations for the Utilization of Technology in Diabetes and he was one of the experts of international task force convened by the American Diabetes Association and the American Podiatric Medical Association to summarize the available evidence on the pathophysiology, natural history, presentations, and treatment recommendations for Charcot Foot.
Dr. Giuseppe Seghieri graduated with cum laude in medicine from the University of Florence, Italy. He did specialization with cum laude in Medical Toxicology (1978), in Gastroenterology (1982), in Clinical Pharmacology (1986), in Internal Medicine (1992) and in Endocrinology (2007). Dr. Seghieri has been the Chief in the department of internal medicine at the Hospital of Pistoia, Italy for more than 20 years. He is a research fellow at the Regional Health Agency of Tuscany, Florence, Italy and also professor of Internal Medicine at the University of Florence (Chair of Physiotherapy). He is (co-) author of more than 150 papers mostly dealing with diabetes and its complications, cardiovascular diseases or gender medicine.
Dr. Vijay Shivaswamy is an endocrinologist in Omaha, Nebraska and is affiliated with multiple hospitals in the area, including Nebraska Medicine-Nebraska Medical Centerand Veterans Affairs Nebraska-Western Iowa Health Care System-Lincoln. He received his medical degree from Bangalore Medical College and has been in practice between 11-20 years.
Dr. Randhir Singh is working as Associate Professor in the Dept of Pharmacology in Central University of Punjab, Bhatinda, India and has an experience of more than 15 years of teaching and research. He has published 120 research and review articles in peer reviewed International Journal and his work is cited in highly reputed journals. He is an editorial board member in several journals. He has supervised 10 Ph.D. Scholars, 12 M. Pharmacy students and12 Pharm D students. He is the recipient of several project grants from government agencies. He received Prof Saroj V.N Sharma award, Best Faculty Award from APP 2017, and South Africa and Eminent Researcher Award from DCM Edutech 2018. He has authored 12 books with reputed publishers of national and international level. His name is included in the Top 2% Researchers in the WORLD, as published by Stanford University, USA in 2021.
Dr. Nicola Troisi received his MD degree magna cum laude from the University “Federico II”, Naples, Italy. He attended the post-doctorate fellowship training at the University of Florence, Italy, and he obtained the title of Specialist in Vascular Surgery (magna cum laude with a final experimental study “New technical solutions for the endovascular treatment of aneurysms of abdominal aorta and of iliac arteries”). He was Clinical Research Fellow at the Department of Vascular Surgery, St. Franziskus Hospital, Münster, Germany and at the Department of Vascular and Endovascular Surgery, University Hospital, Münster, Germany. He authored and co-authored about 170 publications of which 82 published in peer-reviewed scientific journals.
Dr. Vinik is an international leader in basic and clinical neuropathy and neuroendocrine tumors, and isolated INGAP in clinical trials for “Curing” diabetes. He has authored ten books, 124 book chapters, and published more than 500 papers in highly reputable journals. Dr. Vinik received the Virginia Outstanding Scientist Award, was elected a Health Care Hero, received lifetime recognition for contributions to Neuropathy and a distinction in endocrinology. He has served NIH and ADA grant committees and funded by NIH, NIAA, ADA and industry. He holds patents for INGAP and copyrights for the Norfolk Quality of Life DN and NET tools.
Dr. Xu is currently an Assistant Professor and Principal Investigator of Protein-Ligand Interactions and Molecular Medicine Laboratory in the Department of Biochemistry and the Center for Drug Discovery at Virginia Tech in the US. He received his Ph.D. in Biochemistry from Case Western Reserve University School of Medicine in Cleveland, Ohio and did his postdoctoral fellowship at Fred Hutchinson Cancer Research Center in Seattle, Washington. His research focuses on discovery and mechanisms of novel peptide hormones and small molecules relevant to diabetes, obesity (adipocyte browning and thermogenesis agents) and related neurodegeneration. He has published nearly 40 peer-reviewed papers in journals.
Dr. Hanan Farouk Aly , completed her PhD.in physiology. She is working as a professor from 2012 in the Therapeutic Chemistry Department, National Research Center. She has supervised 10 Masters and Ph.D thesis. She has 20 projects in hepatoprtective, natural product and nanoparticle. She is a referee in Journal of Natural product research, Journal of Neuroscience and Behavioral Health, Journal of Medical Sciences. She has 80 papers and 5 books specialized in hepatoprotective role of natural product and metabolic disorders.
Dr. Tapan Behl obtained his Ph.D. degree (in 2017) in Pharmacology from University of Delhi, New Delhi, India. Dr. Behl is currently an Associate Professor in the Department of Pharmacology at Chitkara College of Pharmacy, Chitkara University, Rajpura, India. His skills and expertise mainly lie in the subject areas/fields of Cell Signaling, Apoptosis, Antioxidant Activity, Reactive Oxygen Species, Oxidative Stress, Pathology, Diabetic Complications, etc. Dr. Behl, as an author/co-author, has published more than 15 articles in various journals of international repute.
Dr. Fernandes, did his BSc in Biological Sciences from Mackenzie Presbyterian University and an MSc in Translational Medicine from the Federal University of São Paulo. He completed his PhD in Translational Medicine from Federal University of Sao Paulo and currently he is working as a post-doctoral scholar at the University of Chicago. During his PhD program he worked as a Lab Tech Research at Rush University, in Chicago. He has great interest in studies related to obesity, diabetes, non-alcoholic fatty liver disease, liver-related studies and endocrinology studies. Later on he also studied the importance of Kruppel-like Zinc Fingers in the liver and its relationship with lipid metabolism. He has more than ten years of experience working in a lab environment as a researcher, and has published 13 peer-reviewed scientific papers and review articles.
Dr. Prasant Kumar Jena received his BSc in Biological Sciences and MSc in Biotechnology from Berhampur University. Later, he obtained a Ph.D. in Biotechnology from Nirma University (India). He has more than 9 years of research experience in studying the impact of diet and gut microbiota on the development of metabolic diseases including obesity, diabetes, and carcinogenesis. In his graduate studies, he developed a sugar diet-induced diabetes rat model to study the effect of microbiota and probiotic intervention in lipid and carbohydrate metabolism. Currently, Dr. Jena is working at University of California Davis as a researcher.
Dr Pranav Kumar Prabhakar has received his PhD in Biotechnology from Indian Institute of Technology (IIT) Madras, India during the period of 2011 and he has completed his master in biochemistry from Patna University Bihar, India in 2003. Currently, he is working as Assistant Professor in Lovely Professional University Punjab, India. He has successfully completed his Administrative responsibilities as research coordinator of the school. His research has included synergy, Phytomedicine, metabolic disorders. He is serving as an editorial member of several reputed journals and expert Reviewers for many journals. He has authored 35+ research articles/books/ book chapters. He is a member of Royal Society of Chemistry and Asia-Pacific Chemical, Biological & Environmental Engineering Society (APCBEES).
Dr Bobby Huda is a Consultant and Clinical Lead for Diabetes & Metabolism at St Bartholomew’s and the Royal London Hospitals, and Honorary Senior Lecturer at Barts & the London Medical School, Queen Mary University of London. He trained at Guys & St Thomas NHS foundation trust and Kings College Hospital NHS trust. He was an NIHR academic Lecturer at Kings College London from 2011-2012. He has a PhD in Gut peptides and obesity from the University of Liverpool. His current clinical interests are type 1 diabetes, technology and antenatal diabetes.